A Novel 10‐Protein Score for Liver Fat Content Predicts Cardiovascular‐Kidney‐Metabolic Disease Risk
Advanced Science · 2026
DOI: 10.1002/advs.202515645 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Xiaoqin Gan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of …. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Liver, Fatty Liver, Metabolic Diseases. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Key Technologies R&D Program of Guangdong Province.
Abstract (Originalsprache)
Liver fat content (LFC) is a key biomarker for cardiovascular‐kidney‐metabolic (CKM), yet noninvasive assessment remains challenging. It aims to develop a plasma proteomic‐based LFC score to predict MRI‐derived proton density fat fraction (MRI‐PDFF), evaluate its association with 14 CKM diseases, and explore interactions with polygenic risk scores (PRS). Both the comprehensive 62‐protein and simplified 10‐protein LFC scores are developed and validated in 5,320 UK Biobank participants (96.8% White). The 10‐protein LFC score, comprising proteins involved in adipogenesis, lipid metabolism, and insulin signaling (IGFBP2, FABP4, MET, CPM, CES1, IGFBP1, CDHR2, RBP5, ERBB2, SSC5D), showed superior diagnostic accuracy for hepatic steatosis compared to fatty liver index(FLI) (AUC = 0.850 vs. 0.794). Among 45,444 participants, it exhibited significant associations with 16 cardiometabolic risk markers and 13 incident CKM outcomes, particularly metabolic dysfunction‐associated steatotic liver disease (MASLD), type 2 diabetes (T2D), chronic kidney disease, and coronary heart disease. The score significantly enhanced risk prediction for 8–10 CKM outcomes beyond standard risk factors and FLI (e.g., MASLD,C‐index improved from 0.743 to 0.774; T2D, from 0.773 to 0.806). The score showed significant interactions with PRS for T2D ( P ‐interaction
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, State Key Laboratory of Multi-organ Injury Prevention and Treatment, Guangdong Provincial Inst…
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.
- Institute of Biomedicine, Anhui Medical University, Hefei, China.
ORCID-Profile: Xianhui Qin
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Key Technologies R&D Program of Guangdong Province
- Guangdong Provincial Clinical Research Center for Kidney Disease
- President Foundation of Nanfang Hospital, Southern Medical University
- Program of Introducing Talents of Discipline to Universities, 111 Plan (D18005)
Zitieren
APA
Gan, X., Wei, Y., Wu, Y., Su, X., Wang, G., Yang, S., Ye, Z., Zhang, Y., Xiang, H., Huang, Y., Zhang, Y., Zhang, Y., & Qin, X. (2026). A Novel 10‐Protein Score for Liver Fat Content Predicts Cardiovascular‐Kidney‐Metabolic Disease Risk. Advanced Science. https://doi.org/10.1002/advs.202515645
Vancouver
Gan X, Wei Y, Wu Y, Su X, Wang G, Yang S, et al. A Novel 10‐Protein Score for Liver Fat Content Predicts Cardiovascular‐Kidney‐Metabolic Disease Risk. Advanced Science. 2026. doi:10.1002/advs.202515645
BibTeX
@article{Gan2026,
author = {Gan, Xiaoqin and Wei, Yuanxiu and Wu, Yiting and Su, Xinyue and Wang, Gangling and Yang, Sisi and Ye, Ziliang and Zhang, Yanjun and Xiang, Hao and Huang, Yu and Zhang, Yiwei and Zhang, Yuanyuan and Qin, Xianhui},
title = {A Novel 10‐Protein Score for Liver Fat Content Predicts Cardiovascular‐Kidney‐Metabolic Disease Risk},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202515645}
}
EUVIMED